[Effects of clarithromycin on cytokine expression and NF-kappaB activation in nasal-mucosa derived cultured cells].
Ushigai
M
M
Takagi
M
M
Ohori
J
J
Kurono
Y
Y
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002478:Cells, Cultured; D017291:Clarithromycin / Q000494:pharmacology*; D003864:Depression, Chemical; D004847:Epithelial Cells / Q000378:metabolism; D005347:Fibroblasts / Q000378:metabolism; D006801:Humans; D018836:Inflammation Mediators / Q000378:metabolism*; D018799:Intercellular Adhesion Molecule-1 / Q000378:metabolism; D007375:Interleukin-1 / Q000378:metabolism*; D016328:NF-kappa B / Q000378:metabolism*; D009297:Nasal Mucosa / Q000166:cytology / Q000378:metabolism*
D000900:Anti-Bacterial Agents; D018836:Inflammation Mediators; D007375:Interleukin-1; D016328:NF-kappa B; D018799:Intercellular Adhesion Molecule-1; D017291:Clarithromycin